lysophosphatidylglycerol has been researched along with Atherosclerosis* in 1 studies
1 other study(ies) available for lysophosphatidylglycerol and Atherosclerosis
| Article | Year |
|---|---|
Different origins of lysophospholipid mediators between coronary and peripheral arteries in acute coronary syndrome.
Lysophosphatidic acids (LysoPAs) and lysophosphatidylserine (LysoPS) are emerging lipid mediators proposed to be involved in the pathogenesis of acute coronary syndrome (ACS). In this study, we attempted to elucidate how LysoPA and LysoPS become elevated in ACS using human blood samples collected simultaneously from culprit coronary arteries and peripheral arteries in ACS subjects. We found that: 1) the plasma LysoPA, LysoPS, and lysophosphatidylglycerol levels were not different, while the lysophosphatidylcholine (LysoPC), lysophosphatidylinositol, and lysophosphatidylethanolamine (LysoPE) levels were significantly lower in the culprit coronary arteries; 2) the serum autotaxin (ATX) level was lower and the serum phosphatidylserine-specific phospholipase A Topics: Acute Coronary Syndrome; Atherosclerosis; Coronary Vessels; Female; Heart; Humans; Lysophospholipids; Male; Mass Spectrometry; Phospholipases A1; Phosphoric Diester Hydrolases | 2017 |